AC Immune
Price & Volume
Stats
See more52W Range | $2.03-$4 |
Market Cap | $253.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $17.5M |
Revenue Growth (YoY) | 1,057.2% |
Gross Profit (12 Mos) | -$28.4M |
Diluted EPS | -$0.51 |
News
See moreYahoo Finance • 11 days ago
AC Immune First Half 2026 Financial and Corporate Update
Yahoo Finance • 4 months ago
AC Immune First Quarter 2026 Financial and Corporate Updates
Yahoo Finance • 4 months ago
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease
Yahoo Finance • 4 months ago
Leerink Says AC Immune (ACIU) Eli Lilly Tau Program Amendment Is Great News
About
CEO | Dr. Martin Zugel M.D., Ph.D. |
CFO | Mr. Christopher Roberts |
Address | Building B, Lausanne, Switzerland, 1015 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 90 |